Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress

Physiological Reviews

Volumn 80, Issue 3, 2000, Pages 979-1020

  Slominski, Andrzej ^a,b,c,d,e   Wortsman, Jacobo ^a,b,c,d   Luger, Thomas ^a,b,c,d   Paus, Ralf ^a,b,c,d   Solomon, Samuel ^a,b,c,d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d ROYAL VICTORIA HOSPITAL   (Canada)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; INTERMEDIN; PROOPIOMELANOCORTIN;

CYTOKINE RELEASE; GENE; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SKIN; SKIN MANIFESTATION; STRESS; ULTRAVIOLET RADIATION;

EID: 0033946195     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.2000.80.3.979     Document Type: Review

References (457)

1. ABDEL-MALEK Z, SWOPE VB, SUZUKI I, AKCALI C, HARRIGER MD, BOYCE ST, URABE K, AND HEARING VJ. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 92: 1789-1793, 1995.
2. ABE K, BUTCHER W, NICHOLSON WE, BAIRDE CE, LIDDLE RA, AND LIDDLE GW. Adenosine 3,5-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology 84: 362-368, 1969.
3. ACKLAND JF, SCHWARTZ NB, MAYO KE, AND DODSON RE. Non-steroidal signals originating in the gonads. Physiol Rev 72: 731-787, 1992.
4. ADLER GK, ROSEN LB, FIAND ACA MJ, AND MAJZOUB JA. Protein kinase-C activation increases the quantity and poly(A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells. Mol Endocrinol 6: 476-483, 1992.
5. AGUILERA G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol 9: 329-336, 1998.
6. ALLEN BM. The results of extirpation of the anterior lobe of the hypophysis and of the thyroid of Rana pipiens larvae. Science 44: 755-758, 1916.
7. ALLEN RG, HATFIELD JM, STACK J, AND RONNEKLEIV O. Post-translational processing of proopiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. Adrenocorticotropin (ACTH) and α-melanotropins (α-MSHs). Dev Biol 126: 164-172, 1988.
8. ALLEN RG, ORWELL E, KENDALL JW, HERBERT E, AND PAXTON H. The distribution of forms of adrenocorticotropin and beta-endorphin in normal, tumorous, and autopsy human pituitary tissue: virtual absence of 13K adrenocorticotropin. J Clin Endocrinol Metab 51: 376-380, 1980.
9. ANGIONI S, PETRAGLIA F, GALLINELLI A, COSSARIZZA A, FRANCESCHI C, MUSCETTOLA M, GENAZZANI AG, SURICO N, AND GENAZZANI AR. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci 53: 1735-1742, 1993.
10. AOKI Y, IWASAKI Y, KATAHIRA M, YOISO, AND SAITO H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I. Effects of common segregatogues Endocrinology 138: 1923-1929, 1997.
11. AOKI Y, IWASAKI Y, KATAHIRA M, OISO Y, AND SAITO H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 138: 1930-1940, 1997.
12. ARENDS RJ, VERMEER H, MARTENS GJ, LEUNISSEN JA, WENDELAAR BONGA SE, AND FLIK G. Cloning and expression of two proopiomelanocortin mRNAs in the common carp (Cyprinus carpio L.). Mol Cell Endocrinol 143: 23-31, 1998.
13. ASAKURA H, ZWAIN IH, AND YEN SS. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. J Clin Endocrinol Metab 82: 2720-2725, 1997.
14. ATWELL WJ. On the nature of the pigmentation changes following hypophysectomy in the frog larva. Science 49: 48-50, 1916.
15. AUERNHAMMER CJ, CHESNOKOVA V, AND MELMED S. Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology 139: 2201-2208, 1998.
16. AUERNHAMMER CJ, CHESNOKOVA V, BOUSQUET C, AND MELMED S. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol 12: 954-961, 1998.
17. AUTELITANO DJ, LUNDBLAD JR, BLUM M, AND ROBERTS JL. Hormonal regulation of POMC gene expression. Annu Rev Physiol 51: 715-726, 1989.
18. BAMBERGER CM, WALD M, BAMBERGER AM, ERGÜN S, BEIL FU, AND SCHULTE HM. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83: 708-711, 1998.
19. BARKER DM AND CORDER R. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine. Br J Pharmacol 126: 317-325, 1999.
20. BATEMAN A, SOLOMON S, AND BENNETT HP. Post-translational modification of bovine pro-opiomelanocortin. J Biol Chem 265: 22130-22136, 1990.
21. BECHER E, MAHNKE K, BHAROWAJ R, SCHWARZ T, AND LUGER TA Human dendritic cells express a receptor which is specific for the immunosuppressing neuropeptide α-MSH. J Invest Dermatol 109: 254, 1997.
22. BECHER E, MAHNKE K, BRZOSKA T, KALDEN DH, GRABBE S, AND LUGER TA. Human peripheral blood derived dendritic cells express functional melanocortin receptor MC-1. Ann NY Acad Sci 885: 188-195, 1999.
23. BELON PE. UVA exposure and pituitary secretion: variations of human lipotropin concentrations (βLPH) after UVA exposure. Photochem Photobiol 42: 327-329, 1985.
24. BERNSTEIN JE AND SWIFT R. Relief of intractable pruritus with naloxone. Arch Dermatol 115: 1366-1367, 1979.
25. BERTAGNA X. Proopiomelanocortin-derived peptides. Endocrinol Metab Clin North Am 23: 467-485, 1994.
26. BERTAGNA X, LENNE F, COMAR D, MASSIAS JF, WAJCMAN H, BAUDIN V, LUTON JP, AND GIRARAD F. Human α-melanocyte-stimulating hormone revisited. Proc Natl Acad Sci USA 83: 9719-9723, 1986.
27. BESEDOVSKY HO AND DEL REY A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17: 64-102, 1996.
28. BHARDWAJ RS, BECHER E, MAHNKE K, HARTMEYER M, SCHWARZ T, SCHOLZEN T, AND LUGER TA. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 human monocytes. J Immunol 158: 3378-3384, 1997.
29. BHARDWAJ RS, SCHWARZ A, BECHER E, MAHNKE K, ARAGANE Y, SCHWARZ T, AND LUGER TA. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156: 2517-2521, 1996.
30. BIGLIARDI PL, BIGLIARDI-QI M, BUECHNER S, AND RUFLI T. Expression of μ-opiate receptor in human epidermis and keratin-ocytes. J Invest Dermatol 111: 297-301, 1998.
31. BIRCHALL N, ORLOW SJ, KUPPER T, AND PAWELEK J. Interactions between ultraviolet light and interleukin-1 on MSH binding in both mouse melanoma and human squamous carcinoma cells. Biochem Biophys Res Commun 175: 839-845, 1991.
32. BLALOCK JE. Molecular basis for bidirectional communication between the immune and the neuroendocrine systems. Physiol Rev 69: 1-32, 1989.
33. BLALOCK JE. The syntax of immune-neuroendocrine communication. Immunol Today 15: 504-511, 1994.
34. BOHM M AND LUGER TA. The pilosebaceous unit is part of the skin immune system. Dermatology 196: 75-79, 1998.
35. BOHM M, METZE D, SCHULTE U, BECHER E, LUGER TA, AND BRZOSKA T. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol 8: 453-461, 1999.
36. BOHM M, SCHULTE U, KALDEN H, AND LUGER TA. Alpha-melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann NY Acad Sci 885: 277-286, 1999.
37. BOITANI C, MATHER JP, AND BARDIN CW. Stimulation of adenosine 3′,5′-monophosphate production in rat Sertoli cells by α-melanotropin-stimulating hormone (αMSH) and des-acetyl αMSH. Endocrinology 118: 1513-1518, 1986.
38. BOLOGNIA JL, MURRAY M, AND PAWELEK J. Evidence that UVB-induced melanogenesis is mediated through the MSH receptor system. J Invest Dermatol 92: 651-660, 1989.
39. BOLOGNIA JL, MURRAY-GONZALES M, AND PAWELEK J. Hairless pigmented guinea pigs: a new animal model for studies of the pigmentary system. Pigment Cell Res 3: 150-156, 1990.
40. BOLOGNIA JL, SODI SA, CHAKRABORTY AK, FARGNOLI MC, AND PAWELEK JM. Effects of ultraviolet irradiation on the cell cycle. Pigment, Cell Res 7: 320-325, 1994.
41. BOMIRSKI A, SLOMINSKI A, AND BIGDA J. The natural history of a family of transplantable melanomas in hamsters. Cancer Met Rev 7: 95-119, 1988.
42. BORRELLI E. A chilled-out knockout. Nature Genet 19: 108-109, 1998.
43. BOS JD. Skin Immune System (SIS). Boca Raton FL: CRC, 1997.
44. BOSTON BA, BLAYDON KM, VARNERIN J, AND CONE RD. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278: 1641-1644, 1997.
45. BOSTON BA AND CONE RD. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137: 2043-2050, 1996.
46. BROUXHON SM, PRASAD AV, JOSEPH SA, FELTEN DL, AND BELLINGER DL. Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav Immun 12: 107-122, 1998.
47. BRZOSKA T, KALDEN DH, SCHOLZEN T, AND LUGER TA. Molecular basis of the α-MSH/IL-1 antagonism. Ann NY Acad Sci 885: 230-238, 1999.
48. BRZOSKA T, SCHOLZEN T, BECKER E, HARTMEYER M, BLETZ T, SCHWARZ T, AND LUGER TA. UVB irradiation regulates the expression of proopiomelanocortin, prohormone convertase 1 and melanocortin receptor 1 by human keratinocytes. J Invest Dermatol 108: 622, 1997.
49. BRAR B, SAND ERSON T, WANG N, AND LOWRY JP. Post-translational processing of human procorticotrophin-releasing factor in transfected mouse neuroblastoma and Chinese hamster ovary cell lines. J Endocrinol 154: 431-440, 1997.
50. BRUNETTI L, PREZIOSI P, RAGAZZONI E, AND VACCA M. Involvement of nitric oxide in basal and interleukin-1β-induced CRH and ACTH release in vitro. Life Sci 53: 219-222, 1993.
51. BUFFEY J, THODY AJ, BLEEHEN SS, AND S MACNEIL. α-Melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. J Endocrinol 133: 333-340, 1992.
52. BUGGY JJ. Binding of α-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/ STAT pathway. Biochem J 331: 211-216, 1998.
53. BURCHILL SA AND THODY AJ. Melanocyte-stimulating hormone and the regulation of tyrosinase activity in hair follicular melanocytes of the mouse. J Endocrinol 111: 225-232, 1986.
54. BURCHILL SA, VIRDEN R, FULLER BB, AND THODY AJ. Regulation of tyrosinase synthesis by α-melanocyte-stimulating hormone in hair follicular melanocytes of the mouse. J Endocrinol 116: 17-23, 1988.
55. BUZZETTIR R, MCLOUGHLIN L, LAVENDER PM, CLARK AJ, AND REES LH. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83: 733-737, 1988.
56. CALOGERO AE, BURRELLO N, NEGRI-CESI P, PAPALE L, PULUMBO MA, CIANCI A, SANFILIPPO S, AND D'AGATA R. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology 137: 4161-4166, 1996.
57. CAN G, ABDEL-MALEK Z, PORTER-GILL PA, GILL P, BOYCE S, GRABOWSKI GA, NORDLUND J, AND FAROOQUI J. Identification and sequencing of a putative variant of proopiomelanocortin in human epidermis and epidermal cells in culture. J Invest Dermatol 111: 485-491, 1998.
58. CANNON JG, TATRO JB, REICHLIN S, AND DINARELLO CA. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137: 2232-2236, 1986.
59. CASTRO MG AND MORRISON E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 11: 35-57, 1997.
60. CATANIA A, GERLONI V, PROCACCIA S, AIRAGHI L, MANFREDI MG, LOMATER C, GROSSI L, AND LIPTON JM. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases, comparisons with other anticytokine molecules. Neuroimmunomodulation 1: 321-328, 1994.
61. CATANIA A AND LIPTON JM. Alpha-melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 14: 564-576, 1993.
62. CATANIA A, MANFREDI MG, AIRAGHI L, VIVIRITO MC, CAPETTI A, MILAZZO F, LIPTON JM, AND ZANUSSI C. Plasma concentration of cytokine antagonists in patients with HIV infection. Neuroimmunomodulation 1: 42-49, 1994.
63. CATANIA A, RAJORA N, CAPSONI F, MINONZIO F, STAR RA, AND LIPTON JM. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675-679, 1996.
64. CHAKRABORTY A, BOLOGNIA J, FUNASAKA Y, SLOMINSKI A, BOLOGNIA J, SODI S, ICHIHASHI M, AND PAWELEK JM. UV light and MSH receptors. Ann NY Acad Sci 885: 110-116, 1999.
65. CHAKRABORTY A AND PAWELEK J. MSH receptors in immortalized human epidermal keratinocytes: a potential mechanism for coordinate regulation of the epidermal-melanin unit. J Cell Physiol 157: 344-350, 1993.
66. CHAKRABORTY A, FUNASAKA Y, PAWELEK JM, NAGAHAMA M, ITO A, AND ICHIHASHI M. Enhanced expression of melanocortin-1 receptor (MCl-r) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol 112: 853-860, 1999.
67. CHAKRABORTY A, FUNASAKA Y, SLOMINSKI A, ERMAK G, HWANG J, PAWELEK JM, AND ICHIHASHI M. Production and release of proopiomelanocortin (POMC)-derived peptides by human melanocytes and keratinocytes in culture: regulation by UVB. Biochim Biophys Acta 1313: 130-138, 1996.
68. CHAKRABORTY AK, ORLOW SJ, BOLOGNIA JL, AND PAWELEK J. Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J Cell Physiol 147: 1-6, 1991.
69. CHAKRABORTY AK, ORLOW SJ, AND PAWELEK JM. Stimulation of melanocyte-stimulating hormone receptors by retinoic acid. FEBS Lett 276: 205-208, 1990.
70. CHAKRABORTY AK AND PAWELEK JM. Upregulation of MSH receptor by MSH in Cloudman melanoma cells. Biochem Biophys Res Commun 188: 1325-1331, 1992.
71. CHAKRABORTY AK, SLOMINSKI A, ERMAK G, HWANG J, AND PAWELEK JM. Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for aMSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol 105: 655-659, 1995.
72. CHALLIS JRG. CRH, a placental clock and preterm labour. Nature Med 1: 416, 1995.
73. CHALMERS DT, LOVENBERG TW, AND DE SOUZA EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350, 1995.
74. CHALMERS DT, LOVENBERG TW, GRIGORIADIS DE, BEHAN DP, AND DE SOUZA EB. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17: 166-172, 1996.
75. CHANG AC, CHOCHET M, AND COHEN SN. Structural organization of human genomic DNA encoding pro-opiomelanocortin peptide. Proc Natl Acad Sci USA 77: 4890-4894, 1980.
76. CHANG AC, ISRAEL A, GAZDAR A, AND COHEN SN. Initiation of proopiomelanocortin mRNA from a normally quiescent promoter in a human small cell lung cancer cell line. Gene 84: 115-126, 1989.
77. CHANG CP, PEARSE RV, O'CONNELL S, AND ROSENFELD MG. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11: 1187-1195, 1993.
78. CHEN R, LEWIS KA, PERRIN MH, AND VALE WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967-8971, 1993.
79. CHEN W, KELLY MA, OPITZ-ARAYA X, THOMAS RE, LOW MJ, AND CONE RD. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91: 789-798, 1997.
80. CHESNOKOVA V, AUERNHAMMER CJ, AND MELMED S. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139: 2209-2216, 1998.
81. CHEUNG CC, CLIFTON DK, AND STEINER RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138: 4489-4492, 1997.
82. CHHAJLANI V AND WIKBERG JE. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309: 417-420, 1992.
83. CHIAO H, FOSTER S, THOMAS R, LIPTON J, AND STAR RA. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 97: 2038-2044, 1996.
84. CLARK AJ, LAVENDER PM, BESSER GM, AND REES LH. Proopiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome. J Mol Endocrinol 2: 3-9, 1989.
85. CLARK AJ, LAVENDER PM, COATES P, JOHNSON MR, AND REES LH. In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol Endocrinol 4: 1737-1743, 1990.
86. CLIFTON VL, READ MA, LEITCH IM, GILES WB, BOURA AL, ROBINSON PJ, AND SMITH R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 80: 2888-2893, 1995.
87. CLIFTON VL, TELFER JF, THOMPSON AJ, CAMERON IT, TEOH TG, LYE SJ, AND CHALLIS JR. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J Clin Endocrinol Metab 83: 3716-3721, 1998.
88. CONE RD, LU D, KOPPULA S, VAGE DI, KLUNGLAND H, BOSTON B, CHEN W, ORTH DN, POUTON C, AND KESTERSON RA. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Harm Res 51: 287-318, 1996.
89. DAI R AND STREILEIN JW. Ultraviolet B-exposed and soluble factor-pre-incubated epidermal Langerhans cells fail to induce contact hypersensitivity and promote DNP-specific tolerance. J Invest Dermatol 108: 721-726, 1997.
90. DAY R, SCHAFER , WATSON SJ, CHRETIEN M, AND SEIDAH MKH/NG. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol 6: 485-497, 1992.
91. DEBOLD CR, MENEFEE JK, NICHOLSON WE, AND ORTH DN. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol Endocrinol 2: 862-870, 1988.
92. 31P NMR studies. Proc Natl Acad Sci USA 88: 1506-1510, 1991.
93. DESCHODT-LANCKMAN M, VANNESTE Y, LOUR B, MICHEL A, LIBERT A. CHANEM G, AND LEJEUNE F. Degradation of α-melanocyte stimulating hormone (α-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int J Cancer 46: 1124-1130, 1990.
94. DIBLASIO AM, GIRALDI FP, VIGANO P, PETRAGLIA F, BIGNALI M, AND CAVAGNINI F. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab 82: 1594-1597, 1997.
95. DIPASQUALE A, MCGUIRE J, AND VARGA JM. The number of receptors for α-melanocyte stimulating hormone in Cloudman melanoma cells is increased by dibutyryl adenosine 3′:5′-cyclic mono-phosphate or cholera toxin. Proc Natl Acad Sci USA 74: 601-605, 1977.
96. DISSANAYAKE NS AND MASON RS. Modulation of skin cell functions by transforming growth factor-β1 and ACTH after ultraviolet irradiation. J Endocrinol 159: 153-163, 1998.
97. DONALDSON CJ, SUTTON SW, PERRIN MH, CORRIGAN AZ, LEWIS KA, JERIVIER, VAUGHAN JM, AND VALE WW. Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170, 1996.
98. DORIN RI, ZLOCK DW, AND KILPATRICK K. Transcriptional regulation of human corticotropin releasing factor gene expression by cyclic adenosine 3′,5′-monophosphate: differential effects at proximal and distal promoter elements. Mol Cell Endocrinol 96: 99-111, 1993.
99. DROUIN J, NEMER M, CHARRON J, GAGNER JP, JEANNOTTE L, SUN YL, THERRIEN M, AND TREMBLAY Y. Tissue specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucorticoids. Genome 31: 510-519, 1989.
100. DUFAU ML, TINAJERO JC, AND FABBRI A. Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J 7: 299-307, 1993.
101. EBERLE AN. The Melanotropins: Chemistry, Physiology and Mechanism of Action. New York: Karger, 1988.
102. EHRHART-BORNSTEIN M, HINSON JP, BORNSTEIN SR, ASCHERBAUM W, AND VINSON GP. Intra-adrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19: 101-143, 1998.
103. ERDEN HF, ZWAIN IH, ASAKURA H, AND YEN SS. Corticotropin-releasing factor inhibits luteinizing hormone-stimulated P450c17 gene expression and androgen production by isolated thecal cells of human ovarian follicles. J Clin Endocrinol Metab 83: 448-452, 1998.
104. ERMAK G AND SLOMINSKI A. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol 108: 160-165, 1997.
105. ESHEL Y AND SALOMON Y. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3′,5′-monophosphate production in M2R mouse melanoma cells. Endocrinology 134: 177-185, 1994.
106. EVANS VR, MANNING AB, BERNARD LH, CHRONWALL BM, AND MILLINGTON WR. α-Melanocyte-stimulating hormone and N-acetyl-β-endorphin immunoreactivities are localized in the human pituitary but are not restricted to the zona intermedia. Endocrinology 134: 97-106, 1994.
107. FAROOQUI JZ, MEDRANO EE, ABDEL-MALEK Z, AND NORDLUND J. The expression of proopiomelanocortin and various POMC-derived peptides in mouse and human skin. Ann NY Acad Sci 680: 508-510, 1993.
108. FAROOQUI JZ, MEDRANO EE, BOISSY RE, TIGELAAR RE, AND NORDLUND JJ. Thy-1+ dendritic cells express truncated form of POMC mRNA. Exp Dermatol 4: 297-301, 1995.
109. FAZAL N, SLOMINSKI A, CHOUDHRY MA, WEI ET, AND SAYEED MM. Effect of CRF and related peptides on calcium signalling in human and rodent melanoma cells. FEBS Lett 435: 187-190, 1998.
110. FELING P, BAXTER JD, AND FROHMAN LA. Endocrinology and Metabolism (3rd ed.). New York: McGraw-Hill, 1995.
111. FISCHER EG. Opioid peptides modulate immune functions. Immunopharmacol Immunotoxicol 10: 265-326, 1988.
112. FISHER LA. Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found Symp 172: 243-253, 1993.
113. FITZPATRICK TB, EISEN AZ, WOLFF K, FREEDBERG IM, AND AUSTEN KF. Dermatology in General Medicine. New York: McGraw Hill, 1987.
114. FLEISHER-BERKOVICH S AND DANON A. Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology 136: 4068-4072, 1995.
115. FLEISHER-BERKOVICH S, RIMON G, AND DANON A. Corticotropin releasing factor modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: receptor binding and effects of antagonists. Regul Peptides 77: 121-126, 1998.
116. FLEISHER-BERKOVICH S, RIMON G, AND DANON A. Modulation of endothelial prostaglandin synthesis by corticotropin releasing factor and antagonists. Eur J Pharmacol 353: 297-302, 1998.
117. FODOR M, SLUITER A, FRANKHUIZZEN-SIEREVOGE A, WEIGANT VM, HOOGERIIOUT P, WILDT DJ, AND VERSTEEG DH. Distribution of Lys-gamma2-melanocyte stimulating hormone (Lys-gamma 2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat. Brain Res 731: 182-189, 1996.
118. FUKATA J, IMURA H, AND NAKAO K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J Endocrinol Invest 17: 141-155, 1994.
119. FUNASAKA Y, CHAKRABORTY AK, HAYASHI Y, KOMOTO M, OHASHI A, NAGAHAMA M, INOUE Y, PAWELEK J, AND ICHIHASHI M. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1α, interleukin-1β, endothelin-1 and tumor necrosis factor-α. Br J Dermatol 139: 216-224, 1998.
120. FUNASAKA Y AND ICHIHASHI M. The effect of ultraviolet B induced adult T cell leukemia-derived factor/thioredoxin (ADF/TRX) on survival and growth of human melanocytes. Pigment Cell Res 10: 68-73, 1997.
121. FUNASAKA Y, SATO H, CHAKRABORTY AK, OHASHI A, CHROUSOS GP, AND ICHIHASHI M. Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal melanocytes. J Invest Dermatol Symp Proc 4: 105-109, 1999.
122. FURKERT J, KLUG U, SLOMINSKI A, EICHMULLER S, MEHLIS B, KERTSCHER U, AND PAUS R. Identification and measurement of beta-endorphin levels in the skin during induced hair growth in mice. Biochim Biophys Acta 1336: 315-322, 1997.
123. GANTZ I, KONDA Y, TASHIRO T, SHIMOTO Y, MIWA H, MUNZERT G, WATSON SJ, DEL VALLE J, AND YAMADA T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268: 8246-8250, 1993.
124. GARCIA-GARCIA L, FUENTES JA, AND MANZANARES J. Differential 5-HT-mediated regulation of sites-induced activation of proopiomelanocortin (POMC) gene expression in the anterior and intermediate lobe of the pituitary in male rats. Brain Res 772: 115-120, 1997.
125. GEORGALA S, SCHULPIS KH, PAPACONSTANTINOU ED, AND STRATIGOS J. Raised β-endorphin serum levels in children with atopic dermatitis and pruritus. J Dermatol Sci 8: 125-128, 1994.
126. GESCHWIND II, HUSEBY RA, AND NISHIOKA R. The effect of melanocyte-stimulating hormone on coat color in the mouse. Recent Prog Horm Res 28: 91-130, 1972.
127. GHANEM G, LIENARD D, HANSON P, LEJEUNE F, AND FRUHLING J. Increased serum α-melanocyte stimulating hormone (α-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 22: 535-536, 1986.
128. GHANEM G, LOIR B, HADLEY M, ABDEL MALEK Z, LIBERT A, DEL MARMOL V, LEJEUNE F, LOZANO J, AND GARCIA-BORRON JC. Partial characterization of IR-α-MSH peptides found in melanoma tumors. Peptides 13: 989-994, 1992.
129. GHANEM G, VERSTEGEN J, DE RIJCKE S, HANSON P, VAN ONDERBERGEN A, LIBERT A, DEL MARMOL V, ARNOULD R, VERCAMMEN-GRAND JEAN A, AND LEJEUNE F. Studies on factors influencing human plasma α-MSH. Anticancer Res 9: 1691-1696, 1989.
130. GHANEM G, COMUNALE G, LIBERT A, VERCAMMEN-GRAND -JEAN A, AND LEJEUNE FJ. Evidence for alpha-melanocyte-stimulating hormone (α-MSH) receptors on human malignant melanoma cells, Int J Cancer 41: 248-255, 1988.
131. GHANEM GE, VERSTEGEN J, LIBERT A, ARNOULD R, AND LEJEUNE F. α-Melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. Pigment Cell Res 2: 519-523, 1989.
132. GIRALDI FP AND CAVAGNINI F. Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion. J Clin Invest 101: 2478-2484, 1998.
133. GIRARD JP AND SPRINGER TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 16: 449-457, 1995.
134. GJERDE EA, WOIE KA, WEI ET, AND REED RK. Corticotropin-releasing hormone inhibits lowering of interstitial fluid pressure in rat trachea induced by neurogenic inflammation. Eur J Pharmacol 352: 99-102, 1998.
135. GLINSKI W, BRODECKA H, GLINSKA-FERENZ M, AND KOWALSKI D. Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol 33: 356-361, 1994.
136. GLINSKI W, BRODECKA H, GLINSKA-FERENZ M, AND KOWALSKI D. Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol 75: 9-11, 1995.
137. GOLDSMITH LA. Physiology, Biochemistry, and Molecular Biology of the Skin. New York: Oxford Univ. Press, 1991.
138. GRABBE S, BHARDWAJ RS, MAHNKE K, SIMON MM, SCHWARZ T, AND LUGER TA. Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156: 473-478, 1996.
139. GRAMMATOPOULOS D, DAI Y, CHEN J, KARTERIS E, PAPADOPOULOU N, EASTON AJ, AND HILLHOUSE EW. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 83: 2539-2544, 1998.
140. y/ a hairbulb melanoctyes. J Invest Dermatol 96: 78-84, 1991.
141. HADLEY M. Endocrinology. Englewood Cliffs, NJ: Prentice Hall, 1996.
142. HAGAN P, POOLE S, AND BRISTOW AF. Immunosuppressive activity of corticotrophin-releasing factor. Biochem J 281: 251-254, 1992.
143. HAKANISHI S, TERANISHI Y, WATANABI Y, NOTAKE M, NODA M, KAKIDANI H, INGAMI HJ, AND NUMA S. Isolation and characterization of the bovine corticotropin/betalipotropin precursor gene. Eur J Biochem 115: 429-434, 1981.
144. HARBOUR DV, GALIN FS, HUGHES TK, SMITH EM, AND BLALOCK JE. Role of leukocyte-derived pro-opiomelanocortin peptides in endotoxic shock Circ Shock 35: 181-191, 1991.
145. HARBOUR DV, SMITH EM, AND BLALOCK JE. A novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone cleaving enzyme. J Neurosci Res 18: 95-101, 1987.
146. HARBOUR-McMENAMIN D, SMITH EM, AND BLALOCK JE. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun 48: 813-817, 1985.
147. HARTMEYER M, SCHOLZEN T, BECHER E, BHARDWAJ RS, SCHWARZ T, AND LUGER TA. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol 159: 1930-1937, 1997.
148. HARTWIG AC. Peripheral β-endorphin and pain modulation. Anesth Prog 38: 75-78, 1991.
149. HEDLEY SJ, GAWKRODGER DJ, WEETMAN AP, MORAND INI R, BOEYNAEMS J-M, GHANEM G, AND NEIL SM. α-Melanocyte stimulating hormone inhibits tumour necrosis factor-α stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 138: 536-543, 1998.
150. HEINRICH N, MEYER MR, FURKERT J, SASSE A, BEYERMANN M, BONIGK W, AND BERGER H. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1. Endocrinology 139: 651-658, 1998.
151. HELDWEIN KA, REDICK DL, RITTENBERG MB, CLAYCOMB WC, AND STENZEL-POORE MP. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137: 3631-3639, 1996.
152. 2, PAF and rIL-8. Cytokine 4: 320-328, 1992.
153. HILTZ ME AND LIPTON JM. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11: 979-982, 1990.
154. HINNEY A, BECKER I, HEIBULT O, NOTTEBOM K, SCHMIDT A, ZIEGLER A, MAYER H, SIEGFRIED W, BLUM WF, REMSCHMIDT H, AND HEBEBRAND J. Systematic mutation screening of the proopiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J Clin Endocinol Metab 83: 3737-3741, 1998.
155. HIROBE T. Melanocyte stimulating hormone induces the differentiation of mouse epidermal melanocytes in serum-free culture. J Cell Physiol 152: 337-345, 1992.
156. HOGG N AND BERLIN C. Structure and function of adhesion receptors in leukocyte trafficking. Immunol Today 16: 327-330, 1995.
157. HOLTZMANN H, ALTMEYER P, AND SCHULTZ-AMLING W. Der einfluss ultravioletter strtahlen auf die hypothalamus-hypophysenachse des menschen. Acta Dermatol 8: 119-123, 1982.
158. HOLTZMANN H, ALTMEYER P, STOHR L, AND CHILF GN. Die beemfussung des alpha-MSB durch UVA-bestrahlunger der hautein funktionstest. Hautarzt 34: 294-297, 1983.
159. HORSCH D, DAY R, SEIDAH NG, WEIHE E, AND SCHAFER MK. Immunohistochemical localization of the pro-peptide processing enzymes PC1/PC3 and PC2 in the human anal canal. Peptides 18: 755-760, 1997.
160. HRUBY VJ, WILKES BC, HADLEY ME, AL-OBEIDI F, SAWYER TK, STAPLES DJ, DEVAUX AE, DYM O, CASTRUCCI AM, HINTZ MF, RIEHM JP, AND RAO KR. α-Melanotropin: the minimal active se quence in the frog skin bioassay. J Med Chem 30: 2126-2130, 1987.
161. HUNT G. Melanocyte-stimulating hormone: a regulator of human melanocyte physiology. Pathobiology 63: 12-21, 1995.
162. HYATT P, BELL JB, BHATT K, CHU FW, TAIT JF, TAIT SA, AND WHITLEY GS. Effects of α-melanocyte-stimulating hormone on the cyclic AMP and phospholipid metabolism of rat adrenocortical cells. J Endocrinol 110: 405-416, 1986.
163. IKEDA K, TOHO K, SATO S, EBISAWA T, TOKUDOME G, HOSOYA T, HARADA M, NAKAGAWA O, AND NAKAO K. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250: 298-304, 1998.
164. IM S, MORO O, PENG F, MEDRANO EE, CORNELIUS J, BABCOCK G, NORDLUND JJ, AND ABDEL-MALEK ZA. Activation of the cyclic AMP pathway by α-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res 58: 47-54, 1998.
165. INUI A. Feeding and body-weight regulation by hypothalamic neuropeptides: mediation of the actions of leptin. Trends Neurosci 22: 62-67, 1999.
166. ITOI K, SEASHOLTZ AF, AND WATSON SJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocr J 45: 13-33, 1998.
167. JEANNOTTE L, BURBACH JP, AND DROUIN J. Unusual proopiomelanocortin
168. JOHANSSON O AND LIU PY. α-Melanocyte stimulating hormone (α-MSH)-like immunoreactivity is present in certain normal human keratinocytes. Exp Dermatol 2: 204-208, 1993.
169. JOHANSSON O, LJUNGBERG A, HAN SW, AND VAALASTI A. Evidence for α-melanocyte stimulating hormone containing nerves and neutrophilic granulocytes in the human skin by indirect immunofluorescence. J Invest Dermatol 96: 852-856, 1991.
170. JONES MT AND GILLHAM B. Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol Rev 68: 743-818, 1988.
171. JORDAN SA AND JACKSON IJ. Melanocortin receptors and antagonists regulate pigmentation and body weight, Bioessays 20: 603-606, 1998.
172. KALDEN DH, FASTRICH M, BRZOSKA T, SCHOLZEN T, HARTMEYER M, SCHWARZ T, AND LUBER TA. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced activation of nuclear factor-κB in endothelial cells. J Invest Dermatol 110: 495, 1998.
173. KALDEN DH, FASTRICH M, SCHOLZEN T, BRZOSKA T, AND LUBER TA. α-MSH modulates the expression of LPS-induced adhesion molecules. Exp Dermatol 7: 225, 1999.
174. KALDEN DH, SCHOLZEN T, BRZOSKA T, AND LUGER TA. Mechanisms of the anti-inflammatory effects of α-MSH: role of transcription factor NF-κB and adhesion molecule expression. Ann NY Acad Sci 885: 254-261, 1999.
175. KAMEYAMA K, MONTAGUE PM, AND HEARING VJ. Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons. J Cell Physiol 137: 35-44, 1988.
176. KAMEYAMA K, TANAKA S, ISHIDA Y, AND HEARING VJ. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J din Invest 83: 213-221, 1989.
177. KAPAS S, ORFORD CD, BARKER S, VINSON GP, AND HINSON JP. Studies on the intracellular mechanism of action of κ-melanocyte-stimulating hormone on rat adrenal zona glomerulosa. J Mol Endocrinol 9: 47-54, 1992.
178. KAPAS S, PURBRICK A, BARKER S, VINSON GP, AND HINSON JP. α-Melanocyte-stimulating hormone-induced inhibition of angiotensin II receptor-mediated events in the rat adrenal zona glomerulosa. J Mol Endocrinol 13: 95-104, 1994.
179. KAPAS S, PURBRICK A, AND HINSON JP. Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, α-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem J 305: 433-438, 1995.
180. KARALIS K, SANO H, REDWINE J, LISTWAK S, WILDER RL, AND CHROUSOS GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421-423, 1991.
181. KARTERIS E, GRAMMATOPOULOS D, DAI Y, OLAH KB, GHOBARA TB, EASTON A, AND HILLHOUSE EW. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1α (CRH-1α) and the CRH-C variant receptor. J Clin Endocrinol Metab 83: 1376-1379, 1998.
182. KATAHIRA M, IWASAKI Y, AOKI Y, OISO Y, AND SAITO H. Cytokine regulation of the rat proopio-melanocortin gene expression in AtT-20 cells. Endocrinology 139: 2414-2422, 1998.
183. KAVELAARS A, BERKENBOSCH F, CROISET G, REBALLIEUX RE, AND HEIJNEN CJ. Induction of β-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759-764, 1990.
184. KAWAHITO Y, SANO H, MUKAI S, ASM K, KIMURA S, YAMAMURA Y, KATO H, CHROUSOS GP, WILDER RL, AND KONDO M. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37: 544-551, 1995.
185. KEMP CF, WOODS RJ, AND LOWRY PJ. The corticotrophin-releasing factor-binding protein: an act of several parts. Peptides 19: 1119-1128, 1997.
186. 2+ channels in human epidermoid A-431 cells. Eur J Pharmacol 267: 135-142, 1994.
187. 2+ and inositol trisphosphates in human A-431 cells. Eur J Pharmacol 291: 107-113, 1995.
188. 2+] in human epidermoid A-431 cells. Eur J Pharmacol 329: 237-244, 1997.
189. KIPPENBERGER S, BERNDS A, LOITSCH AS, RAMIREZ-BOSCA A, BEREITER-HAHN J, AND HOLZMANN H. α-MSH is expressed in cultured human melanocytes and keratinocytes. Eur J Dermatol 5: 395-397, 1995.
190. KISHIMOTO T, PEARSE RV II, LIN CR, AND ROSENFELD MG. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Pror Natl Acad Sci USA 92: 1108-1112, 1995.
191. KISS M, WLASCHEK M, BRENNEISEN P, MICHEL G, HOMMEL C, LANGE T, PEUS D, KEMENY L, DOBOZY A, SCHARFFETTER-KOCHANEK K, AND RUZICKA T. α-Melanocyte stimulating hormone induces collagenase/matrix metalloproteinase-1 in human dermal fibroblasts. J Biol Chem 376: 425-430, 1995.
192. 2 receptors. Eur J Endocrinol 139: 238-243, 1998.
193. KORNER A AND PAWELEK J. Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system. Nature 267: 444-447, 1977.
194. KOSTICH WA, CHEN A, SPERLE K, AND LARGENT BL. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mot Endocrinol 12: 1077-1085, 1998.
195. KRAVCHENCO IV AND FURALEV VA. Secretion of immunoreactive corticotropin releasing factor and adrenocorticotropic hormone by T-and B-lymphocytes in response to cellular stress factors. Biochtm Biophy Res Commun 204: 828-834, 1994.
196. KRUDE H, BIEBERMANN H, LUCK W, HORN R, BRABANT G, AND GRUTERS A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet 19: 155-157, 1998.
197. KUCHLER K AND THORNER J. Secretion of peptides lacking hydrophobic signal sequence: the role of adenosine triphosphate-driven membranes translocators. Endocr Rev 13: 499-514, 1992.
198. 2+ entry though L-and P-type channels in rat corticotropes. Endocrinology 137: 2269-2277, 1996.
199. LAFLAMME N, FEUVRIER E, RICHARD D, AND RIVEST S. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemic-ally endotoxin-challenged rats. Neuroscience 88: 223-240, 1999.
200. LEITCH IM, BOURA ALA, BOTTI C, READ MA, WALTERS WA, AND SMITH R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83: 4510-4513, 1998.
201. LERNER AB. The discovery of the melanotropins: a history of pituitary endocrinology. Ann NY Acad Sci 680: 1-12, 1993.
202. LERNER AB AND McGURE J. Effect of alpha-and beta-melanocyte stimulating hormones on the skin color of man. Nature 189: 176-179, 1961.
203. LEVINE N, LEMUS-WILSON A, WOOD SH, ABDEL-MALEK ZA, AL-OBEIDI F, HRUBY VJ, AND HADLEY ME. Stimulation of follicular melanogenesis in the mouse by topical and injected melanotropins. J Invest Dermatol 89: 269-273, 1987.
204. LEVINE N, SHEFTEL SN, EYTAN T, DORR RT, HADLEY ME, WEINRACH JC, ERTL GA, TOTH K, MCGEE DL, AND HRUBY VJ. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266: 2730-2736, 1991.
205. LEVINS PC, CARR DB, FISHER JE, MOMTAZ K, AND PARRISH JA. β-Endorphin and β-lipotropin response to ultraviolet radiation. Lancet 2: 166, 1983.
206. LI HE, HEDGER MP, CLEMENTS JA, AND RISBRIDGER GP. Localization of immunoreactive beta-endorphin and adrenocorticotropic hormone and pro-opiomelanocortin mRNA to rat testicular interstitial tissue macrophages. Biol Reprod 45: 282-289, 1991.
207. LIAW CW, LOVENBERG TW, BARRY G, OLTERSDORF T, DEGRIGORIADIS, AND DE SOUZA EB. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137: 72-77, 1996.
208. LICINIO J, GOLD PW, AND WONG ML. A molecular mechanism for stress-induced alterations in susceptibility to disease. Lancet 346: 104-106, 1995.
209. LIPTON JM AND CATANIA A. Mechanisms of anti-inflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann NY Acad Sci 840: 373-380, 1998.
210. LIPTON JM, CERIANI G, MACALUSO A, MCCOY D, CARNES K, BILTZ J, AND CATANIA A. Anti-inflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation. Ann NY Acad Sci 741: 137-148, 1994.
211. γ3-melanocyte stimulating hormone expression in cutaneous malignant melanoma of nodular type. J Dermatol Sci 10: 203-212, 1998.
212. LIU P-Y, LONTZ W, BONDESSON L, AND JOHANSSON O. The possible role of a, β and β melanocyte stimulating hormone-containing keratinocytes in the initiation of vitiligo vulgaris. Eur J Dermatol 5: 625-630, 1995.
213. LOGAN A AND WEATHERHEAD B. Effects of α-melanocyte-stimulating hormone and [8-arginine] vasotocin upon melanogenesis in vitro. J Endocrinol 91: 501-507, 1981.
214. LOIR B, BOUCHARD B, MORAND INIR, DEL MARMOL V, DERAEMAECKER R, GARCIA-BORRON JC, AND GHANEM G. Immunoreactive α-melanotropin as an autocrine effector in human melanoma cells. Eur J Biochem 244: 923-930, 1997.
215. LOIR B, SALES F, DERAEMAECKER R, MORAND INI R, GARCIA-BORRON JC, AND GHANEM G. α-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis. Eur J Cancer 34: 424-426, 1998.
216. LOLAIT SJ, CLEMENTS JA, MARKWICK AJ, CHENG C, MCNALLY M, SMITH A, AND FUNDER JW. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest 77: 1776-1779, 1986.
217. LOVENBERG TW, LIAW CW, GRIGORIADIS DE, CLEVENGER W, CHALMERS DT, DE SOUZA EB, AND OLTERSDORF T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92: 836-840, 1995.
218. LOWRY PJ, WOODS RI, AND BAIGENT S. Corticotropin releasing factor and its binding protein. Pharmacol Biochem Behav 54: 305-308, 1996.
219. LUGER TA, SCHAUER E, TRAUTINGER F, KRUTMANN J, ANSEL J, SCHWARZ A, AND SCHWARZ T. Production of immunosuppressing melanotropins by human keratinocytes. Ann NY Acad Sci 680: 567-570, 1993.
220. LUGER TA, SCHOLZEN T, BRZOSKA T, BECHER E, SLOMINSKI A, AND PAUS R. Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann NYAcad Sci 840: 381-394, 1998.
221. LUGER TA, SCHWARZ T, KALDEN H, SCHOLZEN T, SCHWARZ A, AND BRZOSKA T. Role of epidermal cell derived α-melanocyte stimulating hormone in ultraviolet light mediated local immunosuppression. Ann NY Acad Sci 885: 209-216, 1999.
222. LUNDBLAD JR AND ROBERTS JL. Regulation of propiomelanocortin gene expression in pituitary. Endocr Rev 9: 135-158, 1988.
223. LUNEC J. PIERON JC, SHERBET GV, AND THODY AJ. Alpha-melanocortin-stimulating hormone immunoreactivity in melanoma cell. Pathobiology 58: 193-197, 1990.
224. LYONS PD AND BLALOCK JE. The kinetics of ACTH expression in rat, leukocyte subpopulations. J Neuroimmunol 63: 103-112, 1995.
225. LYONS PD AND BLALOCK JE. Proopiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 78: 47-56, 1997.
226. MAKRIGIANNAKIS A, MARGIORIS A, MARKOGIANNAKIS E, STOURNARAS C, AND GRAVANIS A. Steroid hormones regulate the release of immunoreactive β-endorphin from the Ishikawa human endometrial cell line. J Clin Endocrinol Met 75: 584-589, 1992.
227. MANNA SK AND AGGARHWAL BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-Kappa-B activation induced by various inflammatory agents. J Immunol 161: 2873-2880, 1998.
228. MAURER M, FISCHER E, HAND JISKI B, VON STEBUT E, ALGER-MISSEN B, BAVAND I A, AND PAUS R. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 77: 319-332, 1997.
229. MAY MJ AND GHOSH S. Signal transduction through NF-kappa B. Immunol Today 19: 80-88, 1998.
230. MAZURKIEWICZ JE, CORLISS D, AND SLOMINSKI AT. Differential temporal and spatial expression of POMC mRNA and of the production of POMC peptides during the murine hair cycle. Ann NY Acad Sci 885: 427-429, 1999.
231. MAZURKIEWICZ JE, ERMAK G, HWANG J, CHHIAP V, CORLISS D, AND SLOMINSKI A. Towards identification of cells expressing POMC in the skin. J Invest Dermatol 104: 636, 1995.
232. MCCUBBIN JA, KAUFFMANN PG, AND NEMEROFF CB. Stress, Neuropeptides, and Systemic Disease. San Diego, CA: Academic, 1991.
233. MCLANE J, OSBER M, AND PAWELEK JM. Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochem Biophys Res Commun 145: 719-725, 1987.
234. 2 phase of the cell cycle. Biochemistry 27: 3743-3747, 1988.
235. MCLEAN M, BISITS A, DAVIES J, WOODS R, LOWRY P, AND SMITH R. A placental clock controlling the length of human pregnancy. Nature Med 1: 460-463, 1995.
236. MCLEOD SD, SMITH C, AND MASON RS. Stimulation of tyrosinase in human melanocytes by pro-opiomelanocortin-derived peptides. J Endocrinol 146: 439-447, 1995.
237. MCLOON LK AND WIRTSCHAFTER J. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid. Invest Ophthalmol Visual Sci 38: 834-841, 1997.
238. MECHANICK JI, LEVIN N, ROBERTS JL, AND AUTELITANO DJ. Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology 131: 518-525, 1992.
239. MELZIG MF. Corticotropin releasing factor inhibits proliferation of AtT-20 cells. In Vitro Cell Dev Biol 30: 741-743, 1994.
240. MEYER WJ HI, SMITH EM, RICHARDS GE, CAVALLO A, MORRILL AC, AND BLALOCK JE. In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J din Endocrinol Metab 64: 98-105, 1987.
241. MILLINGTON WR, EVANS VR, BATTIE CN, BAGASRA O, AND FORMAN LJ. Proopiomelanocortin-derived peptides and mRNA are expressed in rat heart. Ann NY Acad Sci 680: 575-578, 1993.
242. MIYATA I, SHIOTA C, IKEDA Y, OSHIDA Y, CHAKI S, OKUYAMA A, AND INAGAMIT. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amgdala. Biochem Biophys Res Commun 24: 692-696, 1999.
243. MIZUNO TM, KLEOPOULOS SP, BERGEN TH, ROBERTS JL, PRIEST CA, AND MOBBS CV. Hypothalamic proopio-melanocortin mRNA is reduced by fasting and (corrected) in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297, 1998.
244. MOELLMANN G, SLOMINSKI A, KUKLINSKA E, AND LERNER AB. Regulation of melanogenesis in melanocytes. Pigment Cell Res 79-87, 1988.
245. MOODY TW, ZIA F, AND VENUGOPAL R. Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells. Peptides 15: 281-285, 1994.
246. MORAND INI R, BOEYNAEMS JM, HEDLEY SJ, MACNEIL S, AND GHANEM G. Modulation of ICAM-1 expression by alpha-MSH in human melanoma cells and melanocytes. J Cell Physiol 175: 276-282, 1998.
247. MORHENN VB. The physiology of scratching: involvement of pro-opiomelanocortin gene-coded proteins in Langerhans cells. Prog Neurol Endocrinol Immunol 4: 265-267, 1991.
248. MOUNTJOY KG. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol 102: R7-R11, 1994.
249. MOUNTJOY KG, BIRD IM, RAINEY WE, AND CONE RD. ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 99: R17-R20, 1994.
250. MOUNTJOY KG, ROBBINS LS, MORTRUD MT, AND CONE RD. The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251, 1992.
251. MOUNTJOY KG AND WONG J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol 128: 171-177, 1997.
252. MOZZANICA N, VILLA ML, FOPPA S, VIGNATI G, CATTANEO A, DIOTTI R, AND FINZI AF. Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo. J Am Acad Dermatol 26: 693-700, 1992.
253. MUGLIA LJ, JENKINS NA, GILBERT DJ, COPELAND NG, AND MAJZOUB JA. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest 93: 2066-2072, 1994.
254. MUGRIDGE KG, PERRETTI M, GHIARA P, AND PARENTE L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197: 151-155, 1991.
255. NAGAHAMA M, FUNASAKA Y, FERNAND EZ-FREZ ML, OHASHI A, CHAKRABORTY AK, UEDA M, AND ICHIHASHI M. Immunore-activity of α-melanocyte-stimulating hormone, adrenocorticotrophic hormone and α-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Br J Dermatol 138: 981-985, 1998.
256. NAVILLE D, BARJHOUX L, JAILLARD C, SAEZ JM, DURAND P, AND BEGEOT M. Stable expression of normal and mutant human ACTH receptor study of ACTH binding and coupling to adenylate cyclase. Mol Cell Endocrinol 129: 83-90, 1997.
257. NORDLUND JJ, BOISSY RE, HEARING VJ, KING RA, AND PORTONNE J. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford Univ. Press, 1998.
258. OATES EL, ALLAWAY GP, ARMSTRONG GR, BOYAJIAN RA, KEHRL JH, AND PRABHAKAR BS. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J Biol Chem 263: 10041-10044, 1988.
259. OATES EL, ALLAWAY GP, AND PRABHAKAR BS. A potential for mutual regulation of proopiomelanocortin gene and Epstein-Barr virus expression in human lymphocytes. Ann NY Acad Sci 594: 60-65, 1990.
260. ODONOHUE TL AND DORSA DM. The opiomelanotropinergic neuronal and endocrine system. Peptides 3: 353-395, 1982.
261. OHMORI N, ITOI K, TOZAWA F, SAKAI Y, SAKAI K, HORIBA N, DEMURA H, AND SUDA T. Effect of acetylcholine on corticotropine-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rat-s. Endocrinology 136: 4858-4863, 1995.
262. OKI Y, IWABUCHI M, MASUZAWA M, WATANABE F, OZAWA M, IINO K, TOMINAGA T, AND YOSHIMI T. Distribution and concentration of urocortin and effect of adrenalectomy on its content in rat hypothalamus. Life Sci 62: 807-812, 1998.
263. OKOSI A, BRAR BK, CHAN M, SOUZA LDE, SMITH E, STEPHANOU A, LATCHMAN DS, CHOWDREY HS, AND KNIGHT RA. Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32: 167-171, 1998.
264. OREL L, SIMON MM, KARLSEDER J, BHARDWAJ R, TRAUTINGER F, SCHWARZ T, AND LUGER TA. α-Melanocyte-stimulating hormone down-regulates differentiation-driven heat shock protein 70 expression in keratinooytes. J Invest Dermatol 108: 401-405, 1997.
265. ORLOW SJ, CHAKRABORTY AK, AND PAWELEK JM. Retinoic acid is a potent inhibitor of inducible pigmentation in mouse and hamster melanoma cells. J Invest Dermatol 94: 461-464, 1990.
266. ORLOW SJ, HOTCHKISS S, AND PAWELEK JM. Internal binding sites for MSH in wild type and variant Cloudman melanoma cells. J Cell Physiol 142: 129-136, 1990.
267. ORTH DN. Corticotropin-releasing hormone in humans. Endocr Rev 13: 164-191, 1992.
268. OWENS A AND NEMEROFF CB. Physiology and pharmacology of corticotropin releasing factor. Pharmacol Rev 43: 425-473, 1991.
269. PAEZ PEREDA M, SAUER J, PEREZ CASTRO C, FINKIELMAN S, STALLA GK, HOLSBOER F, AND ARZT E. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 136: 5504-5510, 1995.
270. PANERAI AE AND SACERDOTE P. Beta-endorphin in the immune system: a role at last? Immunol Today 18: 317-319, 1997.
271. PAQUET L, ZHOU A, CHANG EY, AND MAINS RE. Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2. Mol Cell Endocrinol 120: 161-168, 1996.
272. PARK HY, RUSSAKOVSKY V, AO Y, FERNAND EZ E, AND GILCHREST BA. α-Melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp Cell Res 227: 70-79, 1996.
273. PAUS R. Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3: 248-258, 1996.
274. PAUS R, BOTCHKAREV VA, BOTCHKAREVA NV, FECHNER K, FURKERT J, ROLOFF B, AND SLOMINSKI A. The skin POMC system (SPS): leads and lessons from the hair follicle. Ann NY Acad Sci 885: 350-363, 1999.
275. PAUS R, HAND JISKI B, CZARNETZKI BM, AND EICHMULLER S. A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol 103: 143-147, 1994.
276. PAUS R, MAURER M, SLOMINSKI A, AND CZARNETZKI BM. Mast cell involvement in murine hair growth. Dev Biol 163: 230-240, 1994.
277. PAUS R, PETERS EM, EICHMUELLER S, AND BOTCHKAREV VA. Neural mechanisms of hair growth control. J Invent Dermatol Symp Proc 2: 61-68, 1998.
278. PAWELEK JM. A cyclic AMP requirement for proliferation of Cloudman S91 melanoma cells. Pigment Cell Res 4: 167-176, 1979.
279. PAWELEK JM. Evidence suggesting that a cyclic AMP-dependent protein kinase is a positive regulator of proliferation in Cloudman S91 melanoma cells. J Cell Physiol 98: 619-625, 1979.
280. PAWELEK JM. Studies on the Cloudman melanoma cell line as a model for the action of MSH. Yale J Biol Med 58: 571-578, 1985.
281. PAWELEK JM. Is human melanogenesis stimulated by cyclic AMP? J Invest Dermatol 94: 499-500, 1990.
282. PAWELEK JM. After dopachrome? Pigment Cell Res 4: 53-62, 1991.
283. PAWELEK JM. Proopiomelanocortin in skin: new possibilities for regulation of skin physiology. J Lab Clin Med 122: 627-628, 1993.
284. PAWELEK JM, CHAKRABORTY AL, OSBER MP, ORLOW SJ, MIN KK, ROSENZWEIG KE, AND BOLOGNIA JL. Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? Pigment Cell Res 5: 348-356, 1992.
285. PAWELEK JM, FLEISCHMANN R, MrLANE J, GUILLETTE B, EMANUEL J, KORNER A, BERGSTROM A, AND MURRAY M. Studies on growth and pigmentation of Cloudman S91 melanoma cells. Pigment Cell Res 6: 521-533, 1984.
286. PAWELEK JM, HALABAN R, AND CHRISTIE G. Melanoma cells with a cyclic AMP growth requirement. Nature 258: 539-540, 1975.
287. PAWELEK JM, KORNER A, BERGSTROM A, AND BOLOGNIA J. New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 286: 617-619, 1980.
288. PAWELEK JM, SANSONE M, KOCH N, CHRISTIE G, HALABAN R, HENDEE J, LERNER AB, AND VARGA JM. Melanoma cells resistant to inhibition of growth by melanocyte-stimulating hormone. Proc Natl Acad Sci USA 72: 951-956, 1975.
289. PAWELEK JM, SANSONE M, MOROWITZ J, MOELLMANN G, AND GODAWSKA E. Genetic control of melanization: isolation and analysis of amelanotic variants from cultured melanotic melanoma cells. Proc Natl Acad Sci USA 71: 1073-1077, 1974.
290. PEAKS JS, JUNG RT, BARTLETT W, BROWNING MC, KENICER K, AND THODY AJ. A case of skin hyperpigmentation due to α-MSH hypersecretion. Br J Dermatol 126: 286-289, 1992.
291. PENG PJ, SAHM UG, DOHERTY RV, KINSMAN RG, MOSS SH, AND POUTON CW. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors. Peptides 7: 1001-1008, 1997.
292. PENHOAT A, JAILLARD C, AND SAEZ JM. Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 86: 4978-4981, 1989.
293. PERKINS AV, WOLFE CD, EBEN F, SOOTHILL P, AND LINTON EA. Corticotropin-releasing hormone-binding protein in human fetal plasma. J Endocrinol 146: 395-401, 1995.
294. PERONE MJ, MURRAY CA, BROWN OA, GIBSON S, WHITE A, LINTON EA, PERKINS AV, LOWENSTEIN PR, AND CASTRO MG. Procorticotropin-releasing hormone: endoproteolytic processing and differential release of its derived peptides within AtT20 cells. Mol Cell Endocrinol 142: 191-202, 1998.
295. PERONE M, WINDEATT S, MORRISON E, SHERING A, TOMASEC P, LINTON E, LOWENSTEIN P, AND CASTRO M. Intracellular retention of the corticotropin-releasing hormone (CRH) precursors within COS-7 cells. J Histochem Cytockem 46: 1193-1197, 1998.
296. PERRIN M, DONALDSON C, CHEN R, BLOUNT A, BERGGREN T, BILEZIKJIAN L, SAWCHENKO P, AND VALE W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92: 2969-2973, 1995.
297. PETRAGLIA F, FLORIO P, NAPPI C, AND GENAZZANI AR. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 17: 156-186, 1996.
298. PETRAGLIA F, FLORIA P, GALLO R, SIMONCINI T, SAVIOZZI M, DI BLASIO AM, VAUGHAN J, AND VALE W. Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81: 3807-3810, 1996.
299. PETRAGLIA F, GARUTI GC, DE RAMUNDO B, ANGIONI S, GENAZZANI AR, AND BILEZIKJIAN LM. Mechanism of action of interleukin-1β in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. Am J Obstet Gynecol 163: 1307-1312, 1990.
300. PETRAGLIA F, POTTER E, CAMERON VA, SUTTON S, BEHAN DP, WOODS RJ, SAWCHENKO PE, LOWRY PJ, AND VALE W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 77: 919-924, 1993.
301. PETRAGLIA F, SANTUZ M, FLORIO P, SIMONCINI T, LUISI S, PLAINO L, GENASSANI AR, GENAZZANI AD, AND VOLPE A. Paracrine regulation of human placenta: control of hormonogenesis. J Reprod Immunol 39: 221-233, 1998.
302. PETRAGLIA F, SAWCHENKO PE, RIVIER J, AND VALE W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328: 717-719, 1987.
303. PETRAGLIA F, TABANELLI S, GALASSI MC, GARUTI GC, MANCINI AC, GENAZZANI AR, AND GURPIDE E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab 74: 1427-1431, 1992.
304. 4 release from the human cell line HMC 1 and human cutaneous mast cells in vitro. J Invest Dermatol 107: 507, 1996.
305. PLOTNIKOFF NP, FAITH RE, MURGO AJ, AND GOOD RA. Cytokines: Stress and Immunity. Boca Raton, FL: CRC, 1999.
306. POMERANTZ SH AND HUANG LC. Effects of β-MSH, cortisol and ACTH on tyrosinase in the skin of newborn hamsters and mice. Endocrinology 87: 302-310, 1970.
307. POTTER E, BEHAN DP, FISCHER WH, LINTON EA, LOWRY PJ, AND VALE WW. Cloning and characterization of the cDNA for human and rat corticotropin releasing factor-binding proteins. Nature 349: 423-426, 1991.
308. POTTER E, SUTTON S, DONALDSON C, CHEN R, PERRIN M, LEWIS K, SAWCHENKO PE, AND VALE W. Distribution of cortico-tropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91: 8777-8781, 1994.
309. POZZOLI G, BILEZIKJIAN LM, PERRIN MH, BLOUNT AL, AND VALE WW. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137: 65-71, 1996.
310. PRIMUS RJ, YEVICH E, BALTAZAR C, AND GALLAGER DW. Auto-radiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychapharmacology 17: 308-316, 1997.
311. QUILLAN JM AND SADEE W. Dynorphin peptides: antagonists of melanocortin receptors. Pharm Res 14: 713-719, 1997.
312. RAJORA N, CERIANI G, CATANIA A, STAR RA, MURPHY MT, AND LIPTON JM. alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59: 248-253, 1996.
313. RAY D AND MELMED S. Pituitary cytokine and growth factor expression and action. Endocr Rev 18: 206-228, 1997.
314. REDONDO P, GARCIA-FONCILLAS J, OKROUJNOV I, AND BANORES E. Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 290: 425-428, 1998.
315. RHEINS LA, COTLEUR AL, KLEIER RS, HOPPENJANS WB, SAUNDER DN, AND NORDLUND JJ. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57BL6 mice. J Invest Dermatol 93: 511-517, 1989.
316. RICHTER RM AND MULVANY MJ. Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application. Peptides 16: 843-849, 1995.
317. ROBBINS LS, NADEAU JH, JOHNSON KR, KELLY MA, ROSELLI-REHFUSS L, EBAACK, MOUNTJOY KG, AND CONE RD. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827-834, 1993.
318. RODRÍGUEZ-LIÑARES B, LINTON EA, AND PHANEUF S. Expression of corticotrophin-releasing hormone receptor mRNA a protein in the human myometrium. J Endocrinol 156: 15-21, 1998.
319. ROE CM, LEITCH IM, BOURA AL, AND SMITH R. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. J Clin Endocrinol Metab 81: 763-769, 1996.
320. ROHDE E, FURDERT J, FECHNER K, BEYERMANN M, MULVANY MJ, RICHTER RM, DENEF C, BIENERT M, AND BERGER H. Corticotropin releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem Pharmacol 52: 829-833, 1996.
321. ROLOFF B, FECHNER K, SLOMINSKI A, FURKERT J, BOTCHKAREV VA, BULFONE-PAUS S, ZIPPER J, KRAUSE E, AND PAUS R. Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors (CRF-R) in murine skin. FASEB J 12: 287-297, 1998.
322. ROSE J. Bilateral adrenalectony induces early onset of summer fur growth in mink (Mustela vison). Comp Biochem Physiol 111: 243-247, 1995.
323. ROSE J. Adrenocorticotropic hormone (ACTH) but not alpha-mel-anocyte stimulating hormone (α-MSH) as a mediator of adrenalectomy induced hair growth in mink. J Invest Dermatol 110: 456-457, 1998.
324. ROSE J AND STERNER M. The role of the adrenal glands in regulating onset of winter fur growth in mink (Mustela vison). J Exp Zool 262: 469-473, 1992.
325. RUST CC AND MEYER RK. Effect of pituitary autografts on hair color in the short-tailed weasel. Gen Comp Endocrinol 11: 548-551, 1968.
326. RUST CC, SHACKELFORD RM, AND MEYER RK. Hormonal control of pelage cycles in the mink. J Mammal 46: 549-565, 1965.
327. SAHU A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y(NPY) are targets of leptin signalling in the hypothalamus. Endocr Rev 139: 795-798, 1998.
328. SAHU SN, EDWARDS-PRASAD J, AND PRASAD KN. Alpha tocopherol succinate inhibits melanocyte-stimulating hormone (MSH)-sensitive adenylate cyclase activity in melanoma cells. J Cell Physiol 133: 585-589, 1987.
329. SAIARDIA AND BORRELLI E. Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol Endocrinol 12: 1133-1139, 1998.
330. SAKAI K, YAMADA M, HORIBA N, WAKUI M, DEMURA H, AND SUDA T. The genomic organization of the human corticotropin-releasing factor type-1 receptor. Gene 219: 125-130, 1998.
331. SAPERSTEIN A, BRAND H, AUDHYA T, NABRISKI D, HUTCHINSON B, ROSENZWEIG S, AND HOLLAND ER CS. Interleukin 1β mediates stress-induced immunosuppression via corticotropin-releasing factor. Endocrinology 130: 152-158, 1992.
332. SCATENA C AND ADLER S. Characterization of a human-specific regulator of placental corticotropin-releasing hormone. Mol Endocrinol 12: 1228-1240, 1998.
333. SCHAFER M, CARTER L, AND STEIN C. Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Pharmacology 91: 4219-4223, 1994.
334. SCHAFER M, MOUSA SA, AND STEIN C. Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol 323: 1-10, 1997.
335. SCHAFER M, MOUSA SA, ZHANG Q, CARTER L, AND STEIN C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 93: 6096-6100, 1996.
336. SCHALLREUTER K, SLOMINSKI A, PAWELEK JM, JIMBOW K, AND GILCHREST BA. What control melanogenesis? Exp Dermatol 7: 143-150, 1998.
337. SCHAUER E, TRAUTINGER F, KOCK A, SCHWARZ A, BHARDWAI R, ANSEL JC, SCHWARZ T, AND LUGER TA. Proopiomelanocortin derived peptides are synthesized and released by human keratino-cytes. J Clin Invest 93: 2258-2262, 1994.
338. SCHILLING L, KANZLER C, SCHMIEDEK P, AND EHRENREICH H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery, Br J Pharmacol 125: 1164-1171, 1998.
339. SCHIOTH HB, MUCENIECE R, LARSSON M, AND WIKBERG JE. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH. J Endocrinol 155: 73-78, 1997.
340. SCHIOTH HB, MUTULIS F, MUCENIECE R, PRUSIS P, AND WIKBERG JE. Selective properties of C-and N-terminals and core residues of the melanocyte-stimulating
341. SCHOLZEN TE, BRZOSKA T, KALDEN DH, HARTMEYER M, LUGER TA, ARMSTRONG CA, AND ANSEL JC. Expression of proopiomelanocortin peptides and prohormone convertases by human dermal microvascular endothelial cells. Ann NY Acad Sci 885: 444-447, 1999.
342. SCHOLZEN TE, BRZOSKA T, KALDEN DH, HARTMEYER M, FASTRICH M, LUGER TA, ARMSTRONG CA, AND ANSEL JC. Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells. Ann NY Acad Sci 885: 239-253, 1999.
343. SCOTT AP AND LOWRY PJ. Adrenocorticotrophic-and melanocyte-stimulating peptides in the human pituitary. Biochem J 139: 593-602, 1974.
344. SEASHOLTZ A, BOURBONAIS F, HARNDEN C, AND CAMPER S. Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene. Mol Cell Neurosci 2: 266-273, 1991.
345. SEIDAH NG, FOURNIER H, BOILEAU G, BENJANNET S, RONDEAU N, AND CHRETIEN M. The cDNA structure of the porcine pro-hormone convertase PC2 and the comparative processing by PC1 and PC2 of the N-terminal glycopeptide segment of porcine POMC. FEBS Lett 310: 235-239, 1992.
346. 1-31 on murine splenocyte proliferation via a noloxone-resistant receptor. Biochem Biophys Res Commun 175: 936-942, 1991.
347. SHALTS E, FENG JY, FERIN M, AND WARDLAW SL. α-Melanocyte-stimulating hormone antagonized the neuroendocrine effects of corticotropin-releasing factor and interleukin-1β in the primate. Endocrinology 131: 132-138, 1992.
348. SHIBAHARA S, MORIMOTO Y, FURUTANI Y, NOTAKE M, TAKAHASHI H, SHIMIZU S, HORIKAWA S, AND NUMA S. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2: 775-779, 1983.
349. SHIMIZU T AND STREILEIN JW. Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 8: 187-193, 1994.
350. SHIZUME K, LERNER AB, AND FITZPATRICK TB. In vitro bioassay for the melanocyte stimulating hormone. Endocrinology 54: 553-560, 1954.
351. SIEGRIST W AND EBERLE AN. Homologous regulation of the MSH receptor in melanoma cells. J Receptor Res 13: 263-281, 1993.
352. SIEGRIST W AND EBERLE AN. Melanocortin and their implication in melanoma. Trends Endocrinol Metab 6: 115-120, 1995.
353. SLOMINSKI A. POMC gene expression in hamster and mouse melanoma cells. FEBS Lett 291: 165-168, 1991.
354. SLOMINSKI A. Identification of β-endorphin, α-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol 7: 213-216, 1998.
355. SLOMINSKI A, BAKER J, ERMAK G, CHAKRABORTY A, AND PAWELEK J. Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 399: 175-176, 1996.
356. SLOMINSKI A, BOTCHKAREV NV, BOTCHKAREV VA, CHAKRABORTY A, LUGER T, UENALAN M, AND PAUS R. Hair cycle dependent production of ACTH in mouse skin. Biochim Biophys Acta 1448: 147-152, 1998.
357. SLOMINSKI A, BOTCHKAREV V, CHOUDHRY M, FAZAL N, FECHNER K, FURKERT J, KRAUSE E, ROLOFF B, SAYEED M, WEI E, ZBYTEK B, ZIPPER J, WORTSMAN J, AND PAUS R. Cutaneous expression of CRH and CRH-R: is there a "skin stress response system?". Ann NY Acad Sci 885: 287-311, 1999.
358. SLOMINSKI A, COSTANTINO R, WORTSMAN J, PAUS R, AND LING N. Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci 50: 1103-1108, 1992.
359. SLOMINSKI A, ERMAK G, HWANG J, CHAKRABORTY A, MAZURKIEWICZ JE, AND MIHM M. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374: 113-116, 1995.
360. SLOMINSKI A, ERMAK G, HWANG J, MAZURKIEWICZ JE, CORLISS D, AND EASTMAN A. The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1289: 247-251, 1996.
361. SLOMINSKI A, ERMAK G, MAZURKIEWICZ JE, BAKER J, AND WORTSMAN J. Characterization of corticotropin releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 83: 1020-1024, 1998.
362. SLOMINSKI A, ERMAK G, AND MIHM M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab 81: 2746-2749, 1996.
363. SLOMINSKI A, HEASLEY D, MAZURKIEWICZ JE, ERMAK G, BAKER J, AND CARLSON JA. Expression of proopiomelanocortin (POMC) derived melanocyte stimulating hormone (MSH) and ACTH peptides in skin of basal cell carcinoma patients. Hum Pathol 30: 208-215, 1999.
364. SLOMINSKI A, JASTREBOFF P, AND PAWELEK J. L-Tyrosine stimulates induction of tyrosinase activity by MSH and reduces cooperative interactions between MSH receptors in hamster melanoma cells. Biosci Rep 9: 579-586, 1989.
365. SLOMINSKI A AND MIHM M. Potential mechanism of skin response to stress. Int J Dermatol 35: 849-851, 1996.
366. SLOMINSKI A, MOELLMANN G, AND KUKLINSKA E. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cAMP levels and tyrosinase activity without inducing melanogenesis. J Cell Sci 92: 551-559, 1989.
367. SLOMINSKI A AND PAUS R. Bomirski melanomas: a versatile and powerful model for pigment cell and melanoma research. Int J Oncol 2: 21-228, 1993.
368. SLOMINSKI A AND PAUS R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 101: 90S-97S, 1993.
369. SLOMINSKI A, PAUS R, AND COSTANTINO R. Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol 96: 172-179, 1991.
370. SLOMINSKI A, PAUS R, AND MAZURKIEWICZ JE. Proopiomelanocortin expression and potential function during induced hair growth in C57BL6 mouse. Ann NY Acad Sci 642: 459-461, 1991.
371. SLOMINSKI A, PAUS R, AND MAZURKIEWICZ JE. Proopiomelano-cortin expression in the skin during induced hair growth in mice. Experientia 48: 50-54, 1992.
372. SLOMINSKI A, PAUS R, PLONKA P, HAND JINSKI B, MAURER M, CHAKRABORTY A, AND MIHM MC JR. Pharmacological disruption of hair follicle pigmentation as a model for studying the melanocyte response to and recovery from cytotoxic damage in situ. J Invest Dermatol 106: 1203-1211, 1996.
373. SLOMINSKI A, PAUS R, PLONKA P, MAURER M, CHAKRABORTY A, PRUSKI D, AND LUKIEWICZ S. Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol 102: 862-869, 1994.
374. SLOMINSKI A, PAUS R, AND SCHADERDORF D. Melanocytes are sensory and regulatory cells of epidermis. J Theor Biol 164: 103-120, 1993.
375. SLOMINSKI A, PAUS R, AND WORTSMAN J. Can some melanotropins modulate keratinocyte proliferation? J Invest Dermatol 97: 747, 1991.
376. SLOMINSKI A, PAUS R, AND WORTSMAN J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 93: C1-C6, 1993.
377. SLOMINSKI A AND PAWELEK J. MSH binding in Bomirski amelanotic hamster melanoma cells is stimulated by L-tyrosine. Biosci Rep 7: 949-954, 1987.
378. SLOMINSKI A AND PAWELEK J. Animals under the sun: effects of UV radiation on mammalian skin. Clin Dermatol 16: 503-515, 1998.
379. SLOMINSKI A, ROLOFF B, ZBYTEK B, WEI ET, FECHNER K, CURRY J, AND WORTSMAN J. Corticotropin releasing hormone (CRH) and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol 36: 211-216, 2000.
380. SLOMINSKI A, ROLOFF B, CURRY J, DAHIYA M, SZCZESNIEWSKI A, AND WORTSMAN J. The skin produces urocortin. J Clin Endocrinol Metab 85: 815-823, 2000.
381. SLOMINSKI A, WORTSMAN J, MAZURKIEWICZ JE, MATSUOKA L, DIETRICH J, LAWRENCE K, GORBANI A, AND PAUS R. Detection of the proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 122: 658-666, 1993.
382. SMITH A, BARCLAY C, QUABA A, SEDOWOFIA K, STEPHEN R, THOMPSON M, WATSON A, AND McINTOSH N. The bigger the burn, the greater the stress. Burns 23: 291-294, 1997.
383. SMITH AI AND FUNDER JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9: 159-179, 1988.
384. SMITH EM, HUGHES TK, HASHEMI F, AND STEFANO GB. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 89: 782-786, 1992.
385. SMITH EM, MORRILL AC, MEYER WJ, AND BLALOCK JE. Corticotropin releasing factor induction of leukocyte-derived immunore-active ACTH and endorphins. Nature 321: 881-882, 1986.
386. SMITH R, HEALY E, SIDDIQUI S, FLANAGAN N, STEIJLEN PM, ROSDAHL I, JACQUES JP, ROGERS S, TURNER R, JACKSON IJ, BIRCH-MACHIN MA, AND REES JE. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 111: 119-122, 1998.
387. SMITH R, MESIANO S, CHAN E, BROWN S, AND JAFFE RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 83: 2916-2920, 1998.
388. SPIESS J, DAUTZENBERG FM, SYDOW S, HAUGER RL, RUHMANN A, BLANK T, AND RADULOVIC J. Molecular properties of the CRF receptor. Trends Endocrinol Metab 9: 140-145, 1998.
389. SPIRO J, PARKER S, OLIVER I, FRASER C, MARKS JM, AND THODY AI. Effect of PUVA on plasma and skin immunoreactive alpha-melanocyte stimulating hormone concentrations. Br J Dermatol 117: 703-707, 1987.
390. STAR RA, RAJORA N, HUANG J, STOCK RC, CATANIA A, AND LIPTON JM. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-MSH. Proc Natl Acad Sci USA 92: 8016-8020, 1995.
391. STENZEL P, KESTERSON R, YEUNG W, CONE RD, RITTENBERG MB, AND STENZEL-POORE MP. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9: 637-645, 1995.
392. STENZEL-POORE M, VALE WW, AND RIVIER C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 132: 1313-1318, 1993.
393. STEPHANOU A, FITZHARRIS P, KNIGHT RA, AND LIGHTMAN SL. Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes. Brain Behav Immun 5: 319-327, 1991.
394. STEPHANOU A, JESSOP DS, KNIGHT RA, AND LIGHTMAN SL. Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 4: 67-73, 1990.
395. STEPHANOU A, OKOSI A, KNIGHT RA, CHOWDREY HS, AND LATCHMAN DS. C/EBP activates the human corticotropin-releasing hormone gene promoter. Mol Cell Endocrinol 134: 41-50, 1997.
396. STEVENS MY, CHALLIS JR, AND LYE SJ. Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in the human myometrium. J Clin Endocrinol Metab 83: 4107-4115, 1998.
397. STURM RA, BOX NF, AND RAMSAY M. Human pigmentation genetics: the difference is only skin deep. Bioessays 20: 712-721, 1998.
398. SUDA T, TOZAWA F, DOBASHI I, HORIBA N, OHMORI N, YAMAKADO M, YAMADA M, AND DEMURA H. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro. J Clin Invest 92: 2790-2795, 1993.
399. SUKHANOV VA, VORONKOVA IM, SHVETS SV, DYAKOV VL, AND MOROZOVA LF. Melanocyte-stimulating hormone (α-MSH) inhibits the growth of human malignant melanoma cells with the induction of phosphatidylinositol and myo-inositol phosphate levels. Biochem Int. 24: 625-632, 1991.
400. SUZUKI I, CONE RD, IM S, NORDLUND J, AND ABDEL-MALEK ZA. Binding of melanotropin hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137: 1627-1633, 1996.
401. SUZUKI I, TADA A, OLLMANN MM, BARSH GS, IM S, LAMOREUX ML, HEARING VJ, NORDLUND JJ, AND ABDEL-MALEK ZA. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 108: 838-842, 1997.
402. TAKAHASHI A, AMEMIYA Y, SARASHI M, SOWER SA, AND KAWAUCHI H. Melanotropin and corticotropin are encoded on two distinct genes in the lamprey, the earliest evolved extant vertebrate. Biochem Biophy Res Commun 213: 490-498, 1995.
403. TAKAHASHI K, TOTSUNE K, SONE M, MURAKAMI O, SATOH F, ARIHARA Z, SASANO H, IINO K, AND MOURI T. Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19: 643-647, 1998.
404. TAKEUCHI S AND TAKAHASHI S. Melanocortin receptor genes in the chicken: tissue distributions. Gen Comp Endocrinol 112: 220-231, 1998.
405. TAMATE HB AND TAKEUCHI T. Action of the e locus of mice in the response of phaeomelanic hair follicles to α-melanocyte-stimulating hormone in vitro. Science 24: 1241-1242, 1984.
406. TATRO JB AND REICHLIN S. Specific receptors for α-melanocyte-stimulating hormone are widely distributed in tissues of rodents. Endocrinology 121: 1900-1907, 1987.
407. TAYLOR AW, STREILEIN JW, AND COUSINS SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11: 1199-1206, 1992.
408. TEOFOLI P, MOTOKI K, LOTTI TM, UITTO J, AND MAUVIEL A. Proopiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp Dermatol 6: 111-115, 1997.
409. THEOHARIDES T, SINGH L, BOUCHER W, PANG X, LETOURNEAU R, WEBSTER E, AND CHROUSOS G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139: 403-413, 1998.
410. THEOHARIDES T, SPANOS C, PANG X, ALFERES L, LIGRIS K, LETOURNEAU R, ROZNIECKI J, WEBSTER E, AND CHROUSOS G. Stress-induced intracranial mast cell degranulation: a corticotrop-in-releasing hormone-mediated effect. Endocrinology 136: 5745-5750, 1995.
411. THODY AJ, RIDLEY K, PENNY RJ, CHALMERS R, FISHER C, AND SHUSTER S. MSH peptides are present in mammalian skin. Peptides 4: 813-816, 1983.
412. THODY AJ AND SHUSTER S. Control and function of sebaceous glands. Physiol Rev 69: 383-416, 1989.
413. THOMPSON RC, SEASHOLTZ AF, AND HERBERT E. Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol Endocrinol 1: 363-390, 1987.
414. THORNTON JE, CHEUNG CC, CLIFTON DK, AND STEINER RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138: 5063-5066, 1997.
415. TIMPL P, SPANGEL R, SILLABER I, KRESSE A, REUL JM, STALLA GK, BLANQUET V, STECKLER T, HOLSBOER F, AND WURST W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet 19: 162-166, 1998.
416. TINAJERO JC, FABBRI A, AND DUFAU ML. Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin. Endocrinology 130: 1780-1788, 1992.
417. TJUVAJEV J, KOLESNIKOV Y, JOSHI R, SHERINSKI J, KOUTCHER L, YZHOU, MATEI C, KOUTCHER J, KREEK MJ, AND BLASBERG R. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 12: 1-10, 1998.
418. TORPY DJ AND CHROUSOS GP. The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. Baillieres Clin Rheumatol 10: 181-198, 1996.
419. TSAI-MORRIS CH, BUCZKO E, GENG Y, GAMBOA-PINTO A, AND DUFAU ML. The genomic structure of the rat corticotropin releasing factor receptor. J Biol Chem 271: 14519-14525, 1996.
420. TURNBULL A, SMITH G, LEE S, VALE WW, LEE K, AND RIVIER C. CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140: 1013-1017, 1999.
421. TURNBULL AV AND RIVIER CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79: 1-71, 1999.
422. TURNBULL AV, VALE W, AND RIVIER C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol 303: 213-216, 1996.
423. UEHARA Y, SHIMIZU H, SATO N, TANAKA Y, SHIMOMURA Y, AND MORI M. Carboxyl-terminal tripeptide of α-melanocyte-stimulating hormone antagonized interleukin-1-induced anorexia. Eur J Pharmacol 220: 119-122, 1992.
424. UHLER M AND HERBERT E. Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 258: 257-261, 1983.
425. UHLER M, HERERT E, DEUSTACHIO P, AND RUDDLE FD. The mouse genome contains two nonallelic pro-opiomelanocortin genes. J Biol Chem 258: 9444-9453, 1983.
426. VALDENAIRE O, GILLER T, BREU V, GOTTOWIK J, AND KILPATRICK G. A new functional isoform of the human CRP2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352: 129-132, 1997.
427. VALE W, SPIESS J, RIVER C, AND RIVER J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394-1397, 1981.
428. VALVERDE P, HEALY E, JACKSON I, REES JL, AND THODY AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet 11: 328-330, 1995.
429. VALVERDE P, HEALY E, SIKKINK S, HALDANE F, THODY AJ, CAROTHERS A, JACKSON IJ, AND REES JL. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 5: 1663-1666, 1996.
430. VAMVAKOPOULOS NC AND CHROUSOS GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev 15: 409-420, 1994.
431. VAN DER KRAAN M, ADAN R, ENTWISTLE M, GISPEN W, BURBACH JP, AND TATRO J. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139: 2348-2355, 1998.
432. VAN TOL EA, PETRUZA P, LUND PK, YAMAUCHI M, AND SARTOR RB. Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats. Gut 39: 385-392, 1996.
433. VAN WIJK PA. VAN NECK JW, RIJNBERK A, CROUGHS RH, AND MOL HA. Proliferation of the murine corticotropic tumor cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol Cell Endocrinol 111: 13-19, 1995.
434. VARGA J, MOELLMANN G, FRITSCH P, GODAWSKA E, AND LERNER A. Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells. Proc Natl Acad Sci USA 73: 559-562, 1976.
435. VARGA JM, DIPASQUALE A, PAWELEK J, MCGUIRE J, AND LERNER A. Regulation of melanocyte-stimulating hormone (MSH) action at the receptor level: discontinuous binding of MSH to synchronized mouse melanoma cells during the cell cycle. Proc Natl Acad Sci USA 71: 1590-1593, 1974.
436. VAUGHAN J, DONALDSON C, BITTENCOURT J, PERRIN MH, LEWIS K, SUTTON S, CHAN R, TURNBULL AV, LOVEJOY D, RIVIER C, RIVIER J, SAWCHENKO PE, AND VALE W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292, 1995.
437. VITA N, LAURENT P, LEFORT S, CHALON P, LELIAS JM, KAGHAD M, LEFUR G, CAPUT D, AND FERRARA P. Primary structure and functional expression of mouse pituitary and human eorticotropin releasing factors receptors. FEBS Lett 335: 1-5, 1993.
438. WAKAMATSU K, GRAHAM A, COOK D, AND THODY JH. Characterization of ACTH peptides in human skin and their activation of melanocortin-1 receptor. Pigment Cell Res 10: 288-297, 1997.
439. WARDLAW SL, MCCARTHY KC, AND CONWELL IM. Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 67: 51-57, 1998.
440. WEI ET, GAO GC, AND THOMAS HA. Peripheral anti-inflammatory actions of corticotropin-releasing factor. Ciba Found Symp 172: 258-268, 1993.
441. WEI ET AND THOMAS HA. Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. Eur J Pharmacol 263: 319-321, 1994.
442. WEI ET, THOMAS HA, CHRISTIAN HC, BUCKINGHAM JC, AND ISHIMOTO TK. D-Amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2-beta receptors. Peptides 19: 1183-1190, 1998.
443. WESTLY HJ, KLEISS AJ, KELLEY KW, WONG PK, AND YUEN PH. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 163: 1589-1594, 1986.
444. WILSON JD, FOSTER DW, KRONENBERG HM, AND LARSEN PR. Williams Textbook of Endocrinology (9th ed.). Philadelphia, PA: Saunders, 1998.
445. WINTZEN M AND GILCHREST BA. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 106: 3-10, 1996.
446. WINTZEN M, YAAR M, BURBACK JP, AND GILCHREST BA. Pro-opiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol 106: 673-678, 1996.
447. WONG G AND PAWELEK J. Control of phenotypic expression of cultured melanoma cells by melanocyte-stimulating hormones. Nature New Biol 241: 2113-215, 1973.
448. WONG G AND PAWELEK J. Melanocyte-stimulating hormone activates preexisting tyrosinase molecules in mouse melanoma cells. Nature 255: 644-646, 1975.
449. WONG G, PAWELEK J, SANSONE M, AND MOROWITZ J. Response of mouse melanoma cells to melanocyte-stimulating hormone. Localization in the G-2 phase of the cell cycle. Nature 248: 351-354, 1974.
450. YAWSEN L, DIEHL N, BRENNAN MB, AND HOCHGESCHWENDER U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nature Med 5: 1066-1070, 1999.
451. YAMAZAKI T, KIMOTO T, HIGUCHI K, OHTA V, KAWATO S, AND KOMINAMI S. Calcium ion as a second messenger for o-nitrophe-nylsulfenyl-adrenocorticotropin (NPS-ACTH) and ACTH in bovine adrenal steroidogenesis. Endocrinology 139: 4765-4771, 1998.
452. YANG Y, THOMPSON DA, DICKINSON CJ, WILKEN J, BARSH GS, KENT SB, AND GANTZ I. Characterization of agouti-related protein binding to melanocortin receptors. Mol Endocrinol 13: 148-155, 1999.
453. ZAGON IS, WU Y, AND MCLAUGHLIN PG. The opioid growth factor, met-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. J Invest Dermatol 106: 490-497, 1996.
454. ZHAO L, DONALDSON CJ, SMITH GW, AND VALE WW. The structures of the mouse and human urocortin genes (Ucn and UCN). Genomics 50: 23-33, 1998.
455. ZHOU A, BLOOMQUIST BT, AND MAINS RE. The prohormone convertases PC1 and PC2 mediate district endorproteolytic cleavages in a strict temporal order during proopiornelanocortin biosynthetic processing. J Biol Chem 268: 1763-1769, 1993.
456. ZOUMAKIS E, MARGIORIS AN, MAKRIGIANNAKIS A, STOURNARAS C, AND GRAVANIS A. Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides. J Endocrinol Invest 20: 158-167, 1997.
457. ZUBAIR A, LAKSHMI MS, AND SHERBET GV. Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma. Anticancer Res 12: 399-402, 1992.